30
Participants
Start Date
December 4, 2019
Primary Completion Date
July 31, 2025
Study Completion Date
March 31, 2026
Descartes-08
Autogolous T-cells expressing a chimeric antigen receptor directed to BCMA
Dent Neurologic Institute, Amherst
Allegheny Health Network, Pittsburgh
University of Pennsylvania, Philadelphia
Virginia Commonwealth University, Richmond
University of North Carolina, Chapel Hill
University of Augusta, Augusta
Neurology Associates, P.A., Orlando
SFM Clinical Research, LLC, Boca Raton
University of South Florida, Tampa
University of Kansas Medical Center Research Institute, Kansas City
University of Colorado Anschutz Medical Campus, Aurora
Profound Research, Carlsbad
University of California Irvine, Irvine
Oregon Health & Science University, Portland
University of Alberta, Edmonton
Lead Sponsor
Cartesian Therapeutics
INDUSTRY